Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Antibiotiki i Khimioterapiya is Scopus-indexed (Q4, CiteScore 0.7), DOAJ. Published by Publishing House OKI.
Checked against the index lists dated .
ISSN 0235-2990Verify ISSN ↗
Publisher: Publishing House OKI
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Infectious Diseases | 306 / 361 | 15th | Q4 |
| Microbiology (medical) | 132 / 147 | 10th | Q4 |
| Microbiology | 183 / 194 | 5th | Q4 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1988–present, best quartile Q4, CiteScore 0.7.
Antibiotiki i Khimioterapiya is Q4 in Infectious Diseases (rank 306 of 361), Q4 in Microbiology (medical) (rank 132 of 147) and Q4 in Microbiology (rank 183 of 194), by CiteScore 2025.
Antibiotiki i Khimioterapiya is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.7, quartile Q4, 15th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.140, quartile Q4, with an H-index of 16.
Antibiotiki i Khimioterapiya is published by Publishing House OKI. Its ISSN is 0235-2990.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
Antibiotiki i Khimioterapiya has an h-index of 9 and a 2-year mean of 0.37 citations per paper (OpenAlex). Its Scopus CiteScore is 0.7, quartile Q4. On 2-year citations it ranks #287 of 354 Scopus journals in Infectious Diseases.
Antibiotiki i Khimioterapiya published 87 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 95 research articles (2025–2026), authors are most often from Russia (88.8%), Czechia (2.5%) and Uzbekistan (2.1%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.